Patents by Inventor Tadashi Kanai

Tadashi Kanai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4713454
    Abstract: (6R)-Tetrahydro-L-biopterin of the following formula: ##STR1## is prepared by catalytically reducing L-erythrobiopterin or an acyl derivative thereof in the presence of an amine, at pH 10-13 and with a platinum-base catalyst and when one or more acyl groups still remain, then removing the acyl groups. (6R)-Tetrahydro-L-biopterin is effective for the treatment of certain serious neuroses and malignant hyperphenylalaniemia. The present invention has succeeded in preparing (6R)-tetrahydro-L-biopterin at a high asymmetric ration R/S and moreover with a high yield. Since the process of this invention makes use of an amine as a base, the process is free from admixture of any inorganic salt and can hence provide high-purity crystals with ease.
    Type: Grant
    Filed: January 23, 1986
    Date of Patent: December 15, 1987
    Assignees: Shiratori Pharmaceutical Co., Ltd., Suntory Limited
    Inventors: Hideaki Sakai, Tadashi Kanai
  • Patent number: 4142041
    Abstract: N.sup.4 -Acyloxy-2,2'-cyclocytidines of the formula: ##STR1## and N.sup.4, 3',5'-tri-O-acyl-2,2'-cyclocytidines of the formula: ##STR2## wherein R' and R are the same and represent an acyl group; which are useful for decreasing the total packed cell volume ratio (T/C%) with respect to ascitic form of Sarcoma 180 in small animals, and thus prolonging their lives.
    Type: Grant
    Filed: August 26, 1977
    Date of Patent: February 27, 1979
    Assignee: Kohjin Co., Ltd.
    Inventors: Tadashi Kanai, Osamu Maruyama, Akiji Aoki